Sign in
WithdrawnNo phase

Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves (PVMS) With Omnipolar Mapping Technology

Key facts

Who runs it
The University of Texas Health Science Center, Houston
Where
Houston, United StatesSee the site
Trial code
Status
Withdrawn
Started
15 Jan 2025
Ended
31 Oct 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • PVS-PVI targeted ablation
  • Wide area circumferential ablation (WACA)
Record updated
28 January 2026
Why it stopped
lack of recruitment after technological advances replaced the study procedure.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Symptomatic paroxysmal AF refractory to at least one Class I or Class III antiarrhythmic medication, intolerance to antiarrhythmic medications, or a preference to not trial antiarrhythmic medications
  • A minimum of one documented AF episode via 12-lead ECG, Holter monitor, or loop recorder
  • Capability to provide informed consent

Who cannot take part

  • Prior history of catheter or surgical ablation for AF or left atrial ablation for atypical flutter
  • Congenital heart disease
  • Significant valve disease (moderate or severe mitral/aortic stenosis or regurgitation)
  • Systemic oral anticoagulation therapy contraindicated, including a history of heparin-induced thrombocytopenia
  • Persistent or permanent AF
  • Reversible causes of AF
  • Pregnancy
  • Known presence of intracardiac thrombus
  • Broad vortex-like connections and no clear PVMS to be targeted

Where in United States

  • The University of Texas Health Science Center at HoustonHouston, United States

About the trial

What the trial wants to find out

The purpose of this study is to compare procedural times and Radiofrequency (RF)applications required for Pulmonary vein myocardial sleeves targeted pulmonary vein ablation (PVS-PVI) , to compare the efficacy of PVS-PVI , to compare the safety of PVS-PVI and to assess other clinical outcomes of PVS-PVI in individuals with symptomatic paroxysmal Atrial fibrillation (AF) using Omnipolar Technology with conventional Wide area circumferential ablation (WACA).

The 2 groups in the trial

  • PVS-PVITreatment being tested

    Treatment: PVS-PVI targeted ablation

  • WACAExisting treatment, for comparison

    Treatment: Wide area circumferential ablation (WACA)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves With Omnipolar Mapping Technology - A Randomized Pilot Trial
Record updated
28 January 2026